Analyst Ratings for Kymera Therapeutics (KYMR)
KYMR Rating Summary
KYMR Price Target Summary
- Highest: $313.00 (Barclays)
- Lowest: $54.00 (BofA Securities)
- Average: $120.05
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$120.05 (+43.8%)
* Over Last 12-Mos
Rating Score: 8.9 / 10
Percentile Rank: 89%
Avg. $ Target:
$120.05 (+43.8%)
* Over Last 12-Mos
Rating Score: 8.9 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/25/2026 | Piper Sandler | Biren Amin | New Coverage | Overweight (N/A) |
N/A (N/A) |
91.01 (83.49) |
-8.26% | Details |
| 1/28/2026 | Barclays | Eliana Merle | New Coverage | Overweight (N/A) |
313.00 (N/A) |
71.06 (83.49) |
17.49% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
